Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Journal of Biomedical Nanotechnology
|
February 19, 2022
A Novel Targeted Delivery of Valeric Acid Using Liposomal Nanoparticles in Treatment of Lung Cell Carcinoma
Hongdou Chen, Jinxiang Wan, Douren Chen
Risk Management and Healthcare Policy
|
December 19, 2023
Study on the Relationship Between the Number of Adverse Drug Reactions of Essential Drugs and Visits: Based on Vector Autoregressive Model
Wan Tang, Hongdou Chen, Zixin Zhang, et al.
Biomed Research International
|
July 10, 2018
Comparative Analysis of ADR on China's National Essential Medicines List (2015 Edition) and WHO Model List of Essential Medicines (19th Edition)
Fangfang Zheng, Hongdou Chen, Yanfang Chen, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
May 13, 2023
Effectiveness of intravenous peramivir for the treatment of influenza A/H3N2 and influenza B/Victoria in hospitalized children
Jinna Wang, Hongdou Chen, Lie Zhuo, et al.
BMC Health Services Research
|
June 4, 2026
Availability, prices and affordability of nationally negotiated antidiabetic medicines in China: a national survey
Wan Tang, Wei Li, Wei Lu, et al.
Oncotarget
|
October 6, 2017
Antitumor immunity induced by VE-cadherin modified DC vaccine
Jing Zhou, Yufeng Xi, Xiyan Mu, et al.
Medicine
|
July 12, 2016
Economic evaluation study (CHEER-compliant): Cost-effectiveness analysis of RAS screening for treatment of metastatic colorectal cancer based on the CALGB 80405 trial
Jing Zhou, Rongce Zhao, Feng Wen, et al.
European Journal of Cancer Care
|
December 12, 2019
Patient-based cost-effectiveness analysis of FOLFIRI versus FOLFOX7 for advanced gastric adenocarcinoma in China: A 4-year prospective randomised phase II study
Feng Wen, Hanrui Zheng, Pengfei Zhang, et al.
Tumori
|
April 9, 2016
Cost-effectiveness analysis of treatments for metastatic pancreatic cancer based on PRODIGE and MPACT trials
Jing Zhou, Rongce Zhao, Feng Wen, et al.
Journal of Pharmaceutical Policy and Practice
|
March 12, 2025
Access to single-inhaler triple medicines for chronic obstructive pulmonary disease in China: a national survey on accessibility and utilisation
Wei Li, Wei Guo, Hongdou Chen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Journal of Biomedical Nanotechnology
|
February 19, 2022
A Novel Targeted Delivery of Valeric Acid Using Liposomal Nanoparticles in Treatment of Lung Cell Carcinoma
Hongdou Chen, Jinxiang Wan, Douren Chen
Risk Management and Healthcare Policy
|
December 19, 2023
Study on the Relationship Between the Number of Adverse Drug Reactions of Essential Drugs and Visits: Based on Vector Autoregressive Model
Wan Tang, Hongdou Chen, Zixin Zhang, et al.
Biomed Research International
|
July 10, 2018
Comparative Analysis of ADR on China's National Essential Medicines List (2015 Edition) and WHO Model List of Essential Medicines (19th Edition)
Fangfang Zheng, Hongdou Chen, Yanfang Chen, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
May 13, 2023
Effectiveness of intravenous peramivir for the treatment of influenza A/H3N2 and influenza B/Victoria in hospitalized children
Jinna Wang, Hongdou Chen, Lie Zhuo, et al.
BMC Health Services Research
|
June 4, 2026
Availability, prices and affordability of nationally negotiated antidiabetic medicines in China: a national survey
Wan Tang, Wei Li, Wei Lu, et al.
Oncotarget
|
October 6, 2017
Antitumor immunity induced by VE-cadherin modified DC vaccine
Jing Zhou, Yufeng Xi, Xiyan Mu, et al.
Medicine
|
July 12, 2016
Economic evaluation study (CHEER-compliant): Cost-effectiveness analysis of RAS screening for treatment of metastatic colorectal cancer based on the CALGB 80405 trial
Jing Zhou, Rongce Zhao, Feng Wen, et al.
European Journal of Cancer Care
|
December 12, 2019
Patient-based cost-effectiveness analysis of FOLFIRI versus FOLFOX7 for advanced gastric adenocarcinoma in China: A 4-year prospective randomised phase II study
Feng Wen, Hanrui Zheng, Pengfei Zhang, et al.
Tumori
|
April 9, 2016
Cost-effectiveness analysis of treatments for metastatic pancreatic cancer based on PRODIGE and MPACT trials
Jing Zhou, Rongce Zhao, Feng Wen, et al.
Journal of Pharmaceutical Policy and Practice
|
March 12, 2025
Access to single-inhaler triple medicines for chronic obstructive pulmonary disease in China: a national survey on accessibility and utilisation
Wei Li, Wei Guo, Hongdou Chen, et al.
Page
of 2